UPDATE 7/25/2022: As previously communicated, all Expanded Access Program (EAP) site activities including enrollment, treatment, and inquiries from the EAP coordinating center, have been completed. As a result, Site IRB Authorization Agreements (IAAs) with Mayo Clinic as the IRB of Record for the EAP are now considered terminated at all sites. This update serves as confirmation that the Mayo IRB requires no further information from EAP sites.
Thank you for your participation in the EAP and for its success in providing convalescent plasma as a potential treatment for COVID-19.